11/10/2025
🌟 Big news for women’s health 🌟
Today, the Food and Drug Administration announced that it will remove the “black box” warning from many hormone therapies used during menopause.
Here’s why this is a good thing:
For over two decades these warnings have cast a blanket caution on hormone therapy for menopause — including risks like heart attack, stroke, dementia and breast cancer — even though newer research shows that for many women (especially those within 10 years of menopause or under ~60) the risks are much lower than originally thought.
The warnings discouraged many women and doctors from using these therapies, potentially denying relief from difficult symptoms like hot flashes, night sweats, sleep issues, bone loss, vaginal dryness.
With the change, therapy can be more personalised, with doctors and women making decisions based on individual risks & benefits — rather than being held back by a blanket fear label.
It signals progress in women’s health: better recognition that research evolves, that treatments shouldn’t be frozen by outdated warnings, and that women deserve full, up-to-date information.
Of course:
✔️ This change doesn’t mean hormone therapy is risk-free — it still needs to be used thoughtfully, under a doctor’s supervision, considering a woman’s health history, age, time since menopause onset, type of therapy.
✔️ If you’re going through menopause symptoms or considering hormone therapy — this could be a good moment to talk with your provider about whether it might be right for you.
For anyone who’s been suffering with symptoms — this is a hopeful shift toward better access and better information. 💬 If you want to talk more about what this means for you or your options, The Bridge Clinic of Alice is ready to serve you!
Hormone therapy drugs have carried box warning labels for years. The Food and Drug Administration is removing them, saying the risks were overstated.
